Knight Therapeutics Inc T.GUD

Phase 3 Data Presentation at Kidney Week 2020 ...

[MrMugsy]

https://www.prnewswire.com/news-releases/ardelyx-announces-data-supporting-efficacy-and-safety-of-tenapanor-a-first-in-class-phosphate-absorption-inhibitor-to-be-presented-at-asns-kidney-week-2020-301149661.html

-----

EOM

[Snowballgrowth]

Interesting, what is this mean for GUD revenues over next 3-5 years ?

[MrMugsy]

You tell me!   I just gather the information where and when I can find it.  It's up to you to push the pencil. But ... What it tells me is ... don't prejudge a Goodman drug deal too early when you don't know what other indications may arise.  Any deal is a good deal if you don't overpay, no matter how small it seems. Looks like a new indication is close at

[JTDOUBLE]

Good find Mug, i think with MNK on BK now Knight should be able to pick up some of the good assets there.. Plus, with all the partnerships here eventually this company will be growing on a much fasters rate.. Goodman is an astute CEO and cheap ..this is very good for those who stays longs here . I been adding more here..

[MrMugsy]

Agreed. Accumulation is the name of the game if you like the way Goodman operates. I noticed that Mallinckrodt is filing for bankruptcy and JNJ is putting aside another billion to pay for opioid lawsuites. I bet that one day, Goodman get's to enjoy the H2S version of Ketoprophen, giving Doctors better choices away from opioids.  Fingers crossed.  It's going to take a little